CCR5 and acute lymphoblastic leukemia: In one of them, Xu et al. engineered CCR5-ablated hematopoietic stem & progenitor cells (HSPC) by CRISPR/Cas9 gene editing and transplanted them into a HIV-1 positive patient, also having acute lymphoblastic leukemia (ALL).